181 related articles for article (PubMed ID: 4275496)
1. Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid.
Claeys H; Vermylen J
Biochim Biophys Acta; 1974 Apr; 342(2):351-9. PubMed ID: 4275496
[No Abstract] [Full Text] [Related]
2. Structural relationship between "glutamic acid" and "lysine" forms of human plasminogen and their interaction with the NH2-terminal activation peptide as studied by affinity chromatography.
Wiman B; Wallén P
Eur J Biochem; 1975 Jan; 50(3):489-94. PubMed ID: 122932
[TBL] [Abstract][Full Text] [Related]
3. Physical and chemical properties of the NH2-terminal glutamic acid and lysine forms of human plasminogen and their derived plasmins with an NH2-terminal lysine heavy (A) chain.
Robbins KC; Boreisha IG; Arzadon L; Summaria L
J Biol Chem; 1975 Jun; 250(11):4044-7. PubMed ID: 123921
[TBL] [Abstract][Full Text] [Related]
4. Studies on the conformational changes of plasminogen induced during activation to plasmin and by 6-aminohexanoic acid.
Sjöholm I
Eur J Biochem; 1973 Nov; 39(2):471-9. PubMed ID: 4272770
[No Abstract] [Full Text] [Related]
5. The importance of the preactivation peptide in the two-stage mechanism of human plasminogen activation.
Walther PJ; Hill RL; McKee PA
J Biol Chem; 1975 Aug; 250(15):5926-33. PubMed ID: 1150667
[TBL] [Abstract][Full Text] [Related]
6. Activation of human plasminogen by urokinase. Partial characterization of a pre-activation peptide.
Walther PJ; Steinman HM; Hill RL; McKee PA
J Biol Chem; 1974 Feb; 249(4):1173-81. PubMed ID: 4273519
[No Abstract] [Full Text] [Related]
7. Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen.
Wallén P; Wiman B
Biochim Biophys Acta; 1972 Jan; 257(1):122-34. PubMed ID: 4257942
[No Abstract] [Full Text] [Related]
8. Two distinct pathways of the streptokinase-mediated activation of highly purified human plasminogen.
McClintock DK; Englert ME; Dziobkowski C; Snedeker EH; Bell PH
Biochemistry; 1974 Dec; 13(26):5334-44. PubMed ID: 4279693
[No Abstract] [Full Text] [Related]
9. The mechanism of activation of rabbit plasminogen by urokinase. Lack of a preactivation peptide.
Sodetz JM; Brockway WJ; Mann KG; Castellino FJ
Biochem Biophys Res Commun; 1974 Sep; 60(2):729-36. PubMed ID: 4278813
[No Abstract] [Full Text] [Related]
10. Isoelectric focusing of human plasminogen, plasmin, and derived heavy (A) and light (B) chains.
Robbins KC; Summaria L
Ann N Y Acad Sci; 1973 Jun; 209():397-404. PubMed ID: 4268482
[No Abstract] [Full Text] [Related]
11. Studies on the isolation of the multiple molecular forms of human plasminogen and plasmin by isoelectric focusing methods.
Summaria L; Arzadon L; Bernabe P; Robbins KC
J Biol Chem; 1972 Jul; 247(14):4691-702. PubMed ID: 4261400
[No Abstract] [Full Text] [Related]
12. Characterization of the NH 2 -terminal glutamic acid and NH 2 -terminal lysine forms of human plasminogen isolated by affinity chromatography and isoelectric focusing methods.
Summaria L; Arzadon L; Bernabe P; Robins KC
J Biol Chem; 1973 May; 248(9):2984-91. PubMed ID: 4700448
[No Abstract] [Full Text] [Related]
13. Molecular biology of human plasminogen. I. Physiochemical properties and microheterogeneity.
Collen D; de Maeyer L
Thromb Diath Haemorrh; 1975 Nov; 34(2):396-402. PubMed ID: 806
[No Abstract] [Full Text] [Related]
14. NH2-terminal sequences of mammalian plasminogens and plasmin S-carboxymethyl heavy (A) and light (B) chain derivatives. A re-evaluation of the mechanism of activation of plasminogen.
Robbins KC; Bernabe P; Arzadon L; Summaria L
J Biol Chem; 1973 Oct; 248(20):7242-6. PubMed ID: 4270330
[No Abstract] [Full Text] [Related]
15. Release of an N-terminal peptide from human plasminogen during activation with urokinase.
Rickli EE; Otavsky WI
Biochim Biophys Acta; 1973 Jan; 295(1):381-4. PubMed ID: 4685077
[No Abstract] [Full Text] [Related]
16. Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-aminocarboxylic acids.
Thorsen S
Biochim Biophys Acta; 1975 May; 393(1):55-65. PubMed ID: 124594
[TBL] [Abstract][Full Text] [Related]
17. Human plasminogen: in vitro and in vivo evidence for the biological integrity of NH2-terminal glutamic acid plasminogen.
Collen D; Ong EB; Johnson AJ
Thromb Res; 1975 Oct; 7(4):515-29. PubMed ID: 1081757
[No Abstract] [Full Text] [Related]
18. A new method of isolation and some properties of the heavy chain of human plasmin.
Rickli EE; Otavsky WI
Eur J Biochem; 1975 Nov; 59(2):441-7. PubMed ID: 128454
[TBL] [Abstract][Full Text] [Related]
19. The heterogeneity of the S-100 protein fraction.
Vincendon G; Zanetta JP; Gombos G
Adv Exp Med Biol; 1972; 32(0):9-19. PubMed ID: 4672012
[No Abstract] [Full Text] [Related]
20. Activation of human plasminogen by an insoluble derivative of urokinase. Structural changes of plasminogen in the course of activation to plasmin and demonstration of a possible intermediate compound.
Wiman B; Wallén P
Eur J Biochem; 1973 Jul; 36(1):25-31. PubMed ID: 4270055
[No Abstract] [Full Text] [Related]
[Next] [New Search]
